[Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
出版信息
Fortschr Med Suppl. 1995;166:1-12.
PMID:7537599
Abstract
摘要
相似文献
1
[Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].[阿夫唑嗪治疗良性前列腺增生。对一种新原理的评估。一项研究报告]
Fortschr Med Suppl. 1995;166:1-12.
2
3
4
[A clinical trial of the treatment of patients with benign prostatic hyperplasia using the alpha 1-adrenoblocker alfuzosin].使用α1-肾上腺素能阻滞剂阿夫唑嗪治疗良性前列腺增生症患者的临床试验
Urol Nefrol (Mosk). 1997 Sep-Oct(5):14-6.
5
Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group.阿夫唑嗪治疗良性前列腺增生：对症状评分、尿流率和残余尿量的影响。一项多中心、双盲、安慰剂对照试验。ALFECH研究组
Scand J Urol Nephrol Suppl. 1994;157:169-76.
6
Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia.α受体阻滞剂治疗有症状的良性前列腺增生症患者的临床结果。
Prog Clin Biol Res. 1994;386:285-9.
7
[New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].[奥地利新批准的专科药物以及关于现有专科药物的新知识。优洛福]
Wien Klin Wochenschr. 1995;107(15):472-6.
8
9
The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.阿尔法受体阻滞剂治疗良性前列腺增生症下尿路症状患者的长期疗效：评估逼尿肌收缩力和膀胱出口梗阻程度对排尿和储尿功能的影响。
Urology. 2011 May;77(5):1177-82. doi: 10.1016/j.urology.2010.10.012. Epub 2011 Jan 22.
10
Clinical management of lower urinary tract symptoms with combined medical therapy.联合药物治疗下尿路症状的临床管理
BJU Int. 2008 Nov;102 Suppl 2:13-7. doi: 10.1111/j.1464-410X.2008.08088.x.
Zotero 插件